Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Vitamin E study

This article was originally published in The Tan Sheet

Executive Summary

Vitamin E study: Anticlotting action of vitamin E quinone may explain the vitamin's observed beneficial effects on heart disease and stroke, University of Pittsburgh researchers note in the August Proceedings of the National Academy of Sciences. "We suggest that the attendant anticoagulant properties of vitamin E quinone 2 be taken into consideration when assessing the effectiveness of vitamin E in attenuating the likelihood of the onset of ischemic heart attack and ischemic stroke," Paul Dowd and Zhizhen Zheng conclude. They add that vitamin E quinone 2's "use as an anticoagulant might be explored as an alternative or supplement to warfarin and Coumadin"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel